Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hamood

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Canadian Anaesthetists' Society Journal|January 1, 1977
An improved percutaneous jetting system for use during microlaryngeal operationsE Carden, G Becker, H Hamood
The Annals of Otology, Rhinology, and Laryngology|September 1, 1976
Percutaneous jet ventilationE Carden, G Becker, H Hamood
Harefuah|July 7, 2000
[Acipimox (Olbetam) as a secondary hypolipemic agent in combined hypertriglyceridemia and hyperlipidemia]D Yeshurun, H Hamood, N Morad, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 11, 2018
Hormone therapy and osteoporosis in breast cancer survivors: assessment of risk and adherence to screening recommendationsR Hamood, H Hamood, I Merhasin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Canadian Anaesthetists' Society Journal|January 1, 1977
An improved percutaneous jetting system for use during microlaryngeal operationsE Carden, G Becker, H Hamood
The Annals of Otology, Rhinology, and Laryngology|September 1, 1976
Percutaneous jet ventilationE Carden, G Becker, H Hamood
Harefuah|July 7, 2000
[Acipimox (Olbetam) as a secondary hypolipemic agent in combined hypertriglyceridemia and hyperlipidemia]D Yeshurun, H Hamood, N Morad, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 11, 2018
Hormone therapy and osteoporosis in breast cancer survivors: assessment of risk and adherence to screening recommendationsR Hamood, H Hamood, I Merhasin, et al.
Pageof 1